Beovu (brolucizumab) is used to treat patients with wet age-related macular degeneration (AMD), a chronic eye disorder. AMD is the leading cause of vision loss for people 50 years and older and it may cause a person to struggle reading fine print and have dark vision blurriness in the center of their vision. Novartis the drug manufacturer of Beovu released a press statement confirming that Beovu may cause “retinal vasculitis and/or retinal vascular occlusion that may result in severe vision loss.”
Symptoms you may have after receiving a Beovu Injection:
- Changes in your vision, including floaters
- Pain or redness in the eye
- Bleeding in or around the eye
- Swelling in the eyelid
- Hives, rash, redness or itching
If you or a loved one have suffered from severe side effects or blindness from a Beovu injection, please call the mass tort Team at Inserra Kelley Sewell to see whether you might be entitled to compensation.